Vivos Therapeutics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Vivos Therapeutics, Inc. (VVOS) reported Increase (Decrease) in Prepaid Expense and Other Assets of $227.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-14
- Vivos Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $61.00K, a 55.80% decline year-over-year.
- Vivos Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $166.00K.
- Vivos Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $209.00K, a 41.22% increase year-over-year.
- Vivos Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$130.00K, a 260.49% decline year-over-year.
- Vivos Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$19.00K, a 111.38% decline from fiscal 2024.
- Vivos Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $167.00K.
- Vivos Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$832.00K.
- Vivos Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$126.00K, a 113.97% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $227.00K 10-Q · filed 2026-08-14 | $436.00K derived: sum of 3 quarters · filed 2026-08-14 | $306.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $166.00K 10-Q · filed 2026-05-20 | $375.00K derived: sum of 2 quarters · filed 2026-05-20 | $245.00K derived: sum of 3 quarters · filed 2026-05-20 | $383.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $209.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $79.00K derived: sum of 2 quarters · filed 2026-04-15 | $217.00K derived: sum of 3 quarters · filed 2026-08-14 | -$19.00K 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | -$130.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $8.00K derived: sum of 2 quarters · filed 2026-08-14 | -$228.00K 10-Q · filed 2025-11-19 | -$80.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $138.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$98.00K 10-Q · filed 2026-08-14 | $50.00K derived: sum of 3 quarters · filed 2026-08-14 | $131.00K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | -$236.00K 10-Q · filed 2026-05-20 | -$88.00K derived: sum of 2 quarters · filed 2026-05-20 | -$7.00K derived: sum of 3 quarters · filed 2026-05-20 | $72.00K derived: sum of 4 quarters · filed 2026-05-20 | ||||
| 2024-12-31 | $148.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $229.00K derived: sum of 2 quarters · filed 2026-04-15 | $308.00K derived: sum of 3 quarters · filed 2026-04-15 | $167.00K 10-K · filed 2026-04-15 | ||||
| 2024-09-30 | $81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | $160.00K derived: sum of 2 quarters · filed 2025-11-19 | $19.00K 10-Q · filed 2025-11-19 | -$134.00K derived: sum of 4 quarters · filed 2025-11-19 | ||||
| 2024-06-30 | $79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-19 | -$62.00K 10-Q · filed 2025-08-19 | -$215.00K derived: sum of 3 quarters · filed 2025-08-19 | -$519.00K derived: sum of 4 quarters · filed 2025-08-19 | ||||
| 2024-03-31 | -$141.00K 10-Q · filed 2025-05-15 | -$294.00K derived: sum of 2 quarters · filed 2025-05-15 | -$598.00K derived: sum of 3 quarters · filed 2025-05-15 | -$871.00K derived: sum of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | -$153.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$457.00K derived: sum of 2 quarters · filed 2025-03-31 | -$730.00K derived: sum of 3 quarters · filed 2025-03-31 | -$832.00K 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$304.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$577.00K derived: sum of 2 quarters · filed 2024-11-14 | -$679.00K 10-Q · filed 2024-11-14 | -$1.35M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | -$273.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$375.00K 10-Q · filed 2024-08-14 | -$1.04M derived: sum of 3 quarters · filed 2024-08-14 | -$987.00K derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$102.00K 10-Q · filed 2024-05-14 | -$769.00K derived: sum of 2 quarters · filed 2024-07-30 | -$714.00K derived: sum of 3 quarters · filed 2024-07-30 | -$908.00K derived: sum of 4 quarters · filed 2024-07-30 | ||||
| 2022-12-31 | -$667.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-07-30 | -$612.00K derived: sum of 2 quarters · filed 2024-07-30 | -$806.00K derived: sum of 3 quarters · filed 2024-07-30 | -$126.00K 10-K/A · filed 2024-07-30 | ||||
| 2022-09-30 | $55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$139.00K derived: sum of 2 quarters · filed 2023-11-14 | $541.00K 10-Q · filed 2023-11-14 | $514.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$194.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-16 | $486.00K 10-Q · filed 2023-08-16 | $459.00K derived: sum of 3 quarters · filed 2023-08-16 | $389.00K derived: sum of 4 quarters · filed 2023-08-16 | ||||
| 2022-03-31 | $680.00K 10-Q · filed 2023-06-08 | $653.00K derived: sum of 2 quarters · filed 2023-06-08 | $583.00K derived: sum of 3 quarters · filed 2023-06-08 | $1.33M derived: sum of 4 quarters · filed 2023-06-08 | ||||
| 2021-12-31 | -$27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$97.00K derived: sum of 2 quarters · filed 2023-03-30 | $647.00K derived: sum of 3 quarters · filed 2023-03-30 | $902.00K 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | -$70.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-12-20 | $674.00K derived: sum of 2 quarters · filed 2022-12-20 | $929.00K 10-Q · filed 2022-12-20 | $928.91K 10-Q · filed 2021-11-15 | $788.26K derived: sum of 4 quarters · filed 2022-12-20 | |||
| 2021-06-30 | $744.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2022-12-20 | $999.00K 10-Q · filed 2022-12-20 | $999.89K 10-Q · filed 2021-08-12 | $858.26K derived: sum of 3 quarters · filed 2022-12-20 | $1.11M derived: sum of 4 quarters · filed 2022-12-20 | |||
| 2021-03-31 | $255.00K 10-Q/A · filed 2022-11-25 | $254.57K 10-Q · filed 2021-05-17 | $114.26K derived: sum of 2 quarters · filed 2022-11-25 | $363.79K derived: sum of 3 quarters · filed 2022-11-25 | $368.39K derived: sum of 4 quarters · filed 2022-11-25 | |||
| 2020-12-31 | -$140.74K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $108.79K derived: sum of 2 quarters · filed 2022-03-31 | $113.39K derived: sum of 3 quarters · filed 2022-03-31 | $114.00K 10-K · filed 2022-03-31 | $114.24K 10-K · filed 2021-03-25 | |||
| 2020-09-30 | $249.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $254.13K derived: sum of 2 quarters · filed 2021-11-15 | $254.74K 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | $4.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $5.21K 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | $608.00 10-Q · filed 2021-05-17 | |||||||
| 2019-12-31 | $271.88K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |